Literature DB >> 16780463

Pediatric anogenital warts: a 7-year review of children referred to a tertiary-care hospital in Montreal, Canada.

Danielle Marcoux1, Karine Nadeau, Catherine McCuaig, Julie Powell, Luc L Oligny.   

Abstract

The objectives of this study were to delineate the clinical characteristics of a hospital-referred pediatric population infected with anogenital warts and to investigate the possible relationships between human papillomavirus types and the identified clinical characteristics. Over a 7-year period, 72 patients under the age of 12 years were seen at our dermatology clinic for anogenital warts, corresponding to a prevalence of 1.7/1000 in our patient population. Sixty-four percent (46/72) were girls. Congenital, prenatal, ascending infections occurred in two subjects. The onset of anogenital warts occurred before age 2 in 28% and between 2 and 6 years of age in 62% of children and tended to be younger in boys. We identified unusual cutaneomucosal serotypes human papillomavirus 7 and 57 (three and eight instances, respectively). The modes of transmission of anogenital warts in children cannot be identified either by the clinical appearance of the lesions or by human papillomavirus typing. We conclude that the best way to identify possible sexual abuse is still by history taking, careful assessment of the socio-clinical context, and physical examination.

Entities:  

Mesh:

Year:  2006        PMID: 16780463     DOI: 10.1111/j.1525-1470.2006.00218.x

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN: 0736-8046            Impact factor:   1.588


  16 in total

1.  Human papillomavirus and anogenital warts in children.

Authors:  Amy Ornstein; Todd Hatchette
Journal:  CMAJ       Date:  2011-11-21       Impact factor: 8.262

2.  Reproductive health of adolescent girls perinatally infected with HIV.

Authors:  Yin Ling Woo; Jane Carolyn Sterling
Journal:  Am J Public Health       Date:  2007-09-27       Impact factor: 9.308

3.  Cutaneous mimickers of child abuse: a primer for pediatricians.

Authors:  Mohammed AlJasser; Sultan Al-Khenaizan
Journal:  Eur J Pediatr       Date:  2008-07-26       Impact factor: 3.183

4.  Anogenital Warts in Childhood - Always a Marker for Sexual Abuse?

Authors:  S Bussen; M Sütterlin; U Schmidt; D Bussen
Journal:  Geburtshilfe Frauenheilkd       Date:  2012-01       Impact factor: 2.915

5.  Transplacental Transmission of Human Papillomavirus.

Authors:  Anca Florina Zgura; Elvira Bratila; Simona Vladareanu
Journal:  Maedica (Buchar)       Date:  2015-06

6.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 7.  Anogenital warts in pediatric population.

Authors:  Miguel Costa-Silva; Inês Fernandes; Acácio Gonçalves Rodrigues; Carmen Lisboa
Journal:  An Bras Dermatol       Date:  2017 Sep-Oct       Impact factor: 1.896

Review 8.  Medical and legal implications of testing for sexually transmitted infections in children.

Authors:  Margaret R Hammerschlag; Christina D Guillén
Journal:  Clin Microbiol Rev       Date:  2010-07       Impact factor: 26.132

Review 9.  Human papilloma virus (HPV) infection in children and adolescents.

Authors:  Ioannis N Mammas; George Sourvinos; Demetrios A Spandidos
Journal:  Eur J Pediatr       Date:  2008-12-03       Impact factor: 3.183

Review 10.  Is administration of the HPV vaccine during pregnancy feasible in the future?

Authors:  Abbey B Berenson; Pooja R Patel; Alan D Barrett
Journal:  Expert Rev Vaccines       Date:  2013-11-28       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.